Video

Dr. Sandra Demaria on Radiation and Immunotherapy Combination Regimens

Sandra Demaria, MD, assistant professor of Radiation Oncology, (Interim), Radiation Oncology, Weill Cornell Medical College and New-York Presbyterian, discusses the synergy with radiation therapy and immunotherapy as a potential combination regimen for patients with cancer.

Sandra Demaria, MD, assistant professor of Radiation Oncology, (Interim), Radiation Oncology, Weill Cornell Medical College and New-York Presbyterian, discusses the synergy with radiation therapy and immunotherapy as a potential combination regimen for patients with cancer.

Radiation therapy has various effects on patients depending on the way it is administered, Demaria explains. Nevertheless, there is a synergy that exists between radiation therapy and immunotherapy that has an effect on the tumor microenvironment.

Evidence suggests that T-cell responses can occur with such a combination, she adds, while ongoing research is examining additional immunotherapy and radiation therapy agents. This is particulary interesting, Demaria says, because radiation therapy is readily available; however, it could now be administered in a completely different way to induce a systemic effect on tumors.

Related Videos
Funda Meric-Bernstam, MD
Bhavana Pothuri, MD
Kristen Spencer, DO
Laurence Albigès, MD, PhD
Nirav Shah, MD, MSHP, discusses evaluating zamtocabtagene autoleucel in patients with relapsed/refractory diffuse large B-cell lymphoma.
Bhagirathbhai Dholaria, MBBS
Sairah Ahmed, M.D
Joshua K. Sabari, MD
Barry W. Goy, MD
Fred Saad, CQ, MD, FRCS, FCAHS, director, Prostate Cancer Research, Montreal Cancer Institute, Centre Hospitalier de l’Université de Montréal; full professor, Department of Surgery, Université de Montréal; uro-oncologist, Urology Department, University of Montreal Health Center